Pancreatic Cancer Research

ResearcherUniversity of LeicesterNo recent work listed

William P. Steward

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5109832911. Sources: ClinicalTrials.gov.

Their work

Papers
8
Trials
1
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: none · 2013: 2 papers · 2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers

Papers 8

  1. Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intrave… Co-author DOI 10.21037/atm.2020.02.02↗
  2. Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Intravenous Omega 3 Compared with Controls Co-author DOI 10.21203/rs.3.rs-36878/v1↗
  3. A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2017.495↗
  4. Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.clnu.2013.09.017↗
  5. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an … Co-author DOI 10.1016/s1470-2045(14)70236-0↗
  6. Restoration of mannose-binding lectin complement activity is associated with improved outcome in patients with advanced pancreatic cancer treated with gemcitab… Co-author DOI 10.1177/0148607113476304↗
  7. Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer. Co-author DOI 10.1097/coc.0b013e3182124216↗
  8. Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with g… Co-author DOI 10.1111/hpb.12002↗

Trials 1

  1. A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer Study director NCT01019382↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew S. Metcalfe · 6 shared papers, 1 shared trial, 2009–2020 · strength 0.43
  2. Ashley Robert Dennison · 6 shared papers, 1 shared trial, 2009–2020 · strength 0.43
  3. Ali Raza Arshad · 6 shared papers, 2013–2020 · strength 0.39
  4. Wen Yuan Chung · 5 shared papers, 2013–2020 · strength 0.35
  5. John Isherwood · 4 shared papers, 2014–2020 · strength 0.30
  6. Franscois Runau · 2 shared papers, 2020 · strength 0.20
  7. Alan Anthoney · 2 shared papers, 2014–2018 · strength 0.09
  8. David J. Propper · 2 shared papers, 2014–2018 · strength 0.09
  9. Daniel H. Palmer · 1 shared paper, 2018 · strength 0.06
  10. Natalie Cook · 1 shared paper, 2018 · strength 0.06
  11. Aarthi Gopinathan · 1 shared paper, 2018 · strength 0.06
  12. Bristi Basu · 1 shared paper, 2018 · strength 0.06
  13. David Arthur Tuveson · 1 shared paper, 2018 · strength 0.06
  14. Duncan Ian Jodrell · 1 shared paper, 2018 · strength 0.06
  15. Gary Middleton · 1 shared paper, 2014 · strength 0.03
  16. Victoria E. Shaw · 1 shared paper, 2014 · strength 0.03
  17. Paul J. Ross · 1 shared paper, 2014 · strength 0.03
  18. John P. Neoptolemos · 1 shared paper, 2014 · strength 0.03
  19. William Greenhalf · 1 shared paper, 2014 · strength 0.03
  20. David Cunningham · 1 shared paper, 2014 · strength 0.03
  21. Juan W. Valle · 1 shared paper, 2014 · strength 0.03
  22. Pippa G. Corrie · 1 shared paper, 2014 · strength 0.03
  23. Eithne Costello · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.